You are here
Home 🌿 Medical Cannabis News 🌿 If her daughter was sick and weed could help, U.S. congresswoman says she would break the rules, too 🌿News Categories
If her daughter was sick and weed could help, U.S. congresswoman says she would break the rules, too

A Virginia congresswoman could picture herself defying U.S. federal law if her own daughter was sick and a marijuana medication would help, she told a couple whose daughter uses cannabis to combat symptoms of a rare form of brain cancer.
Whispering to Melanie Davis, Madison’s mother, Democratic Rep. Elaine Luria told her in a video posted on Facebook, “I’d want to do the same thing for my daughter if I ever had to make that choice.”
Although not facing that choice, Luria said an immediate fix would be for the U.S. to remove cannabis from Schedule 1, deemed by the Drug Enforcement Administration as drugs, substances or chemicals with no currently accepted medical use and a high potential for abuse. Schedule 1 includes cannabis, heroin, LSD, ecstasy, methaqualone and peyote.
“I think we need to bring it into a system where it’s prescribable by doctors, there’s better research and understandability of it, there’s regulation of the actual product,” she said in the video.
The released video is a short clip from the documentary, Little but Fierce.
In the clip, the congresswoman and Davis discuss how the Schedule I status of weed inhibits research and limits patient access.
Luria noted in a tweet last week that with cannabis being on Schedule 1, “Madison’s mother could lose her child [to] protective services. I can’t sit when archaic laws cause undue hardships on children.”
Luria supported the Medical Marijuana Research Act, tabled last year and approved last month, which would establish a new, separate registration process for manufacturers of cannabis for research. As per the bill, the DEA “must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.”
She has also co-sponsored legislation to federally deschedule cannabis and allow veterans to access cannabis for therapeutic purposes, according to Marijuana Moment.
“Times are changing,” Davis said in the video clip. “We will see change in our lifetime,” she added.
“I want Madison to go to college, or not go to college. I want Madison to like boys or like girls. I want Madison to be a dancer or a kicker on the football team. I want her to have the childhood that every child deserves. I want her to be happy and I want her to live,” Davis notes on the film’s website.
420 Intel is Your Source for Marijuana News
420 Intel is the leading source for cannabis news from around the world. Get the latest updates on cannabis legalization, politics and technology, as well as developments in medical and recreational marijuana news. Our commitment is to bring you the most important cannabis news stories every day of the week.
At 420 Intel we understand that effective marijuana industry news coverage is a constant endeavor. Every day stories develop regarding cannabis legalization, technological developments, and the medicinal benefits of marijuana use. Each new development carries the potential to impact the marijuana industry regionally, nationally, and internationally. 420 Intel is the marijuana industry news outlet that will keep you up to date on these developments and how they impact the world around you.
With the marijuana industry constantly evolving, you need a cannabis news outlet to keep you abreast of the pertinent information. At 420 Intel, we cover marijuana legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.